CG Oncology, Inc. Common stock (CGON) Financials
Key financial figures for CG Oncology, Inc. Common stock (Q2 2026).
- Revenue
- $1M
- Net Income
- -$79M
- EPS
- $-0.90
- Total Assets
- $1.1B
- Operating Cash Flow
- -$46M
Full income statement, balance sheet, and cash flow for CG Oncology, Inc. Common stock on SentiSense.